BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ELRIG Announces Drug Discovery 2012 Keynotes and Workshops


8/14/2012 9:48:49 AM

Cambridge, UK, 14 August 2012: ELRIG (European Laboratory Robotics Interest Group) today announced details of the keynote speakers and workshop programme for its 6th Annual Drug Discovery Conference. ELRIG is also calling for abstract submissions (posters@elrig.org) for the main poster sessions and for the SLAS Young Scientist Award, the winner of which will be awarded with an expenses paid trip to present and participate in the Student Poster Competition at SLAS2013, 12th-16th January 2013 in Florida.

Keynote presentations will be given by Dr Steve Rees, Vice-President of Screening Sciences and Sample Management at AstraZeneca, and Section President of SLAS (‘Collaborative Models for Lead Discovery’), and Dr Chris Moxham, Associate Vice President at ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company (‘Eli Lilly and Co.'s Open Innovation Drug Discovery Initiative’). The keynote speakers will also close the meeting with a debate on ‘The Evolving Landscape for Drug Discovery’.

A number of vendor workshop sessions will be held during the event, as well as lunchtime ‘Informatics: Making Knowledge from Laboratory Data’ Seminars on both days of the event. The lunchtime Informatics Seminars are: ‘How best to enable externalisation of drug discovery’ and ‘Knowledge at your finger tips’.

Workshop sessions include: ‘Deeper insights – better prediction of drug safety and efficacy’ from GE Healthcare Drug Discovery Suite; and ‘Early drug de-risking with 3D-cell-culture systems’ with InSphero.

Drug Discovery 2012 is to be held on 5th – 6th September 2012 at the Manchester Central Convention Complex, and features over 100 exhibitor booths, an Innovation Zone, Media Area, Careers Zone and Dragons Den. Registration for the event is free and over 1,000 delegates are expected to attend.

To find out more and to register for the conference please visit www.ELRIG.org

About ELRIG

ELRIG is a rapidly growing not-for-profit special interest group focused on the use of robotics and associated technologies in the laboratory and also on the wider applications of laboratory automation.

Membership consists of scientists, researchers, developers, engineers and business-people who are interested in robotics, automation and associated technological developments plus users and vendors of equipment and accessories in this field. ELRIG’s primary objective is to provide an open communication forum for users and vendors, within which members can be educated, share information and experience and network with other members.

Contact

Katie Odgaard

Zyme Communications

Tel: +44 (0)7787 502 947

Email: katie.odgaard@zymecommunications.com

Twitter: zymecomms



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES